158 related articles for article (PubMed ID: 24294011)
1. Erratum: Atazanavir-bilirubin interaction: a pharmacokinetic-pharmacodynamic model [Corrigendum].
Clin Pharmacol; 2013; 5():175. PubMed ID: 24294011
[TBL] [Abstract][Full Text] [Related]
2. Atazanavir-bilirubin interaction: a pharmacokinetic-pharmacodynamic model.
Lozano R; Domeque N; Apesteguia AF
Clin Pharmacol; 2013; 5():153-9. PubMed ID: 24106429
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum.
Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum.
J Indian Soc Periodontol; 2021; 25(3):270. PubMed ID: 34158698
[TBL] [Abstract][Full Text] [Related]
5. ERRATUM.
Int J Bioprint; 2020; 6(4):309. PubMed ID: 33102924
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum].
Clinicoecon Outcomes Res; 2017; 9():231. PubMed ID: 28458569
[TBL] [Abstract][Full Text] [Related]
7. Extended mathematical model for "in vivo" quantification of the interaction betweeen atazanavir and bilirubin.
Lozano R; Domeque N; Apesteguia AF
J Clin Pharmacol; 2014 Feb; 54(2):161-7. PubMed ID: 24243081
[TBL] [Abstract][Full Text] [Related]
8. Erratum: corrigendum.
Clin Ophthalmol; 2011; 5():1557. PubMed ID: 22125401
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum.
Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
[TBL] [Abstract][Full Text] [Related]
10. Erratum: Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators [Corrigendum].
Clin Epidemiol; 2019; 11():245. PubMed ID: 31040719
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators [Corrigendum].
Clin Epidemiol; 2018; 10():223. PubMed ID: 29535555
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Involvement of up-regulation of miR-210 in a rat epilepsy model [Corrigendum].
Neuropsychiatr Dis Treat; 2017; 13():2003-2004. PubMed ID: 28794634
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Anatomical model broncho-trainer: A new training device: Corrigendum.
Sharma MK; Verma AK; Gupta BK; Somvanshi R; Singh C; Arya S
Indian J Anaesth; 2014 Sep; 58(5):679. PubMed ID: 25533552
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant [Corrigendum].
Int J Nanomedicine; 2018; 13():4845. PubMed ID: 30214192
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():245. PubMed ID: 30718950
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum].
Int J Nanomedicine; 2018; 13():6497. PubMed ID: 30410334
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Extraglottic airway devices: technology update [Corrigendum].
Med Devices (Auckl); 2018; 11():27. PubMed ID: 29379320
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Quick reference guide to apixaban [Corrigendum].
Vasc Health Risk Manag; 2017; 13():413. PubMed ID: 29138570
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Humanistic and economic burden of fibromyalgia in Japan [Corrigendum].
J Pain Res; 2016; 9():1161. PubMed ID: 27980435
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Smoking cessation in Asians: focus on varenicline [Corrigendum].
Patient Prefer Adherence; 2015; 9():1075. PubMed ID: 26251580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
